Effects of continuous ingestion of hesperidin and glucosyl hesperidin on vascular gene expression in spontaneously hypertensive rats

Journal of Nutritional Science and Vitaminology

Volumn 59, Issue 5, 2013, Pages 470-473

  Yamamoto, Masaki ^a   Jokura, Hiroko ^a   Suzuki, Atsushi ^a   Hase, Tadashi ^a   Shimotoyodome, Akira ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Glucosyl hesperidin; Hesperidin; Hypertension; NAD(P)H oxidase; Thromboxane A2

Indexed keywords

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; ENZYME REPRESSION; GLUCOSIDES; HESPERIDIN; HYPERTENSION; MALE; NADPH OXIDASE; PROTEIN SUBUNITS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; SOLUBILITY; THROMBOXANE B2; THROMBOXANE-A SYNTHASE; VASCULAR RESISTANCE;

EID: 84892569359     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.59.470     Document Type: Note

References (25)

1. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK. 2002. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76: 93-99.
2. Garg A, Garg S, Zaneveld LJ, Singla AK. 2001. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15: 655-669.
3. Wilmsen PK, Spada DS, Salvador M. 2005. Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53: 4757-4761.
4. Bok SH, Lee SH, Park YB, Bae KH, Son KH, Jeong TS, Choi MS. 1999. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 129: 1182-1185.
5. Galati EM, Trovato A, Kirjavainen S, Forestieri AM, Rossitto A, Monforte MT. 1996. Biological effects of hesperidin, a Citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat. IL Farmaco 51: 219-221.
6. Yamada M, Tanabe F, Arai N, Mitsuzumi H, Miwa Y, Kubota M, Chaen H, Kibata M. 2006. Bioavailability of glucosyl hesperidin in rats. Biosci Biotechnol Biochem 70: 1386-1394.
7. Ohtsuki K, Abe A, Mitsuzuwi H, Kondo M, Uemura K, Iwasaki Y, Kondo Y. 2002. Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J Nutr Sci Vitaminol 48: 420-422.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. 1993. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474.
9. Taddei S, Virdis A, Mattei P, Salvetti A. 1993. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933.
10. Tesfamariam B, Halpern W. 1988. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 11: 440-444.
11. Luscher TF, Vanhoutte PM. 1986. Endotheliumdependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8: 344-348.
12. Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, Saito I. 2006. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 24: 1065-1073.
13. Roberts LJ 2nd, Sweetman BJ, Oates JA. 1978. Metabolism of thromboxane B2 in the monkey. J Biol Chem 253: 5305-5318.
14. Hamberg M, Svensson J, Samuelsson B. 1975. Thromboxane: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994-2998.
15. Touyz RM. 2004. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252.
16. McIntyre M, Bohr DF, Dominiczak AF. 1999. Endothelial function in hypertension: the role of superoxide anion. Hypertension 34: 539-545.
17. Spieker LE, Noll G, Ruschitzka FT, Maier W, Luscher TF. 2000. Working under pressure: the vascular endothelium in arterial hypertension. J Hum Hypertens 14: 617-630.
18. Griendling KK, Sorescu D, Ushio-Fukai M. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501.
19. 22production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276: 29251-29256.
20. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. 2001. Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894.
21. Yamamoto M, Jokura H, Suzuki A, Shimotoyodome A, Hase T. 2012. Effects of hesperetin, a citrus flavonoid, on NADPH oxidase in vascular endothelial cells. Jpn Pharmacol Ther 40: 213-218.
22. Yamamoto M, Suzuki A, Jokura H, Yamamoto N, Hase T. 2008. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats. Nutrition 24: 470-476.
23. Purkerson ML, Martin KJ, Yates J, Kissane JM, Klahr S. 1986. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats. Hypertension 8: 1113-1120.
24. Chen LS, Ito T, Ogawa K, Shikano M, Satake T. 1984. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension. Jpn Heart J 25: 1001-1009.
25. 2synthase in human vascular smooth muscle cells: inhibition with iloprost. Eur J Pharmacol 658: 187-192.